9/18
Health Sciences
New approach accurately identifies medications most toxic to the liver
A Penn Medicine-led study developed a novel approach to using health care data to measure rates of liver injury, as the current method of counting cases is not providing an accurate picture.
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer
Patients with stage 4 lung cancer show high response rates after an anti-inflammatory drug is added temporarily to immune checkpoint inhibitor therapy.
Gender-affirming care at Penn Medicine: A future ‘not in the shadows’
The Penn Medicine Program for LGBTQ+ Health and gender-affirming care at Penn Medicine has helped Mattie Chaya Kimberly “Kimi” Klauser and others get the right care in an open, safe, and nurturing environment.
Text reminders about COVID-19 boosters are as effective as free rides, new study finds
In a new megastudy, Katy Milkman of the Wharton School and collaborators at Penn’s Behavior Change for Good Initiative led research on reminders and free rides to and from pharmacies to boost COVID-19 vaccination rates.
Avoidable deaths during COVID-19 associated with chronic hospital nurse understaffing
A new first-of-its-kind study from Penn Nursing shows that individuals with COVID-19 were more likely to die in hospitals that were chronically understaffed before the pandemic.
Connecting the West Philadelphia community to careers
The West Philadelphia Skills Initiative is a workforce development partnership between the University City District, Penn Medicine, and the University committed to develop career opportunities for local residents.
Replacing registered nurses in high stakes hospital care is dangerous to patients
A new Penn Nursing study shows that substituting registered nurses with lower-wage staff in hospital care is linked with more deaths, readmissions, longer hospital stays, poorer patient satisfaction, and higher costs of care.
Kotaro Sasaki and his team unveil the genetics of testicular cancer
Researchers from Penn Vet develop the first in vitro seminoma model, shedding light on chromosomal anomalies and signaling pathways.
Identifying connections between adverse childhood events and substance use disorders
New research from Penn Medicine finds that people with anxiety and substance use disorders reported experiencing more adverse childhood experiences and lacking protective factors, such as close family connections, that can mitigate their harms.
Who, What, Why: Nursing student and Peace Corps alum Eva Farrell
Serving in the Peace Corps as a math and science teacher in Kenya from 2012 to 2014 inspired MSN student Eva Farrell to go into nursing.
In the News
She’s an expert on OCD at Penn. It still took a while to recognize the disorder in her five-year-old son
Emily Becker-Haimes of the Perelman School of Medicine shares how she recognized OCD in her son’s behavioral habits.
FULL STORY →
You’ve lost weight taking new obesity drugs. What happens if you stop?
Mitchell A. Lazar of the Perelman School of Medicine says that there’s no “magic bullet” for lowering the dosage of weight-loss medication while keeping the weight off.
FULL STORY →
Dementia may not be as common among Parkinson’s patients as thought
A study by Daniel Weintraub of the Perelman School of Medicine suggests that dementia is not inevitable with Parkinson’s and is actually less common than presumed.
FULL STORY →
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Second brain implant by Elon Musk’s Neuralink: Will it fare better than the first?
Anna Wexler of the Perelman School of Medicine and Leonard Davis Institute says that Elon Musk’s predictions for Neuralink’s health care capabilities risk misleading potential study volunteers.
FULL STORY →